资本眼 一周行情 上周（6月1日至7日），医药生物指数下跌4.77%，跑输上证指数3.77个百分点。创新药（BK1106）周内下跌4.62%；恒生医疗保健业指数（HSCICH）周内下跌6.80%；港股创新药ETF广发（513120）周内下跌8.00%。 机构观点 中信建投：“2026ASCO”——中国新药全线发力迈入新阶段 美国临床肿瘤学会（ASCO）年会是全球肿瘤临床研究领域最核心的...
Source Link资本眼 一周行情 上周（6月1日至7日），医药生物指数下跌4.77%，跑输上证指数3.77个百分点。创新药（BK1106）周内下跌4.62%；恒生医疗保健业指数（HSCICH）周内下跌6.80%；港股创新药ETF广发（513120）周内下跌8.00%。 机构观点 中信建投：“2026ASCO”——中国新药全线发力迈入新阶段 美国临床肿瘤学会（ASCO）年会是全球肿瘤临床研究领域最核心的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.